Literature DB >> 31081125

VEGFA From Early Osteoblast Lineage Cells (Osterix+) Is Required in Mice for Fracture Healing.

Evan G Buettmann1,2, Jennifer A McKenzie1, Nicole Migotsky1,2, David Aw Sykes3, Pei Hu1, Susumu Yoneda1, Matthew J Silva1,2.   

Abstract

Bone formation via intramembranous and endochondral ossification is necessary for successful healing after a wide range of bone injuries. The pleiotropic cytokine, vascular endothelial growth factor A (VEGFA) has been shown, via nonspecific pharmacologic inhibition, to be indispensable for angiogenesis and ossification following bone fracture and cortical defect repair. However, the importance of VEGFA expression by different cell types during bone healing is not well understood. We sought to determine the role of VEGFA from different osteoblast cell subsets following clinically relevant models of bone fracture and cortical defect. Ubiquitin C (UBC), Osterix (Osx), or Dentin matrix protein 1 (Dmp1) Cre-ERT2 mice (male and female) containing floxed VEGFA alleles (VEGFAfl/fl ) were either given a femur full fracture, ulna stress fracture, or tibia cortical defect at 12 weeks of age. All mice received tamoxifen continuously starting 2 weeks before bone injury and throughout healing. UBC Cre-ERT2 VEGFAfl/fl (UBC cKO) mice, which were used to mimic nonspecific inhibition, had minimal bone formation and impaired angiogenesis across all bone injury models. UBC cKO mice also exhibited impaired periosteal cell proliferation during full fracture, but not stress fracture repair. Osx Cre-ERT2 VEGFAfl/fl (Osx cKO) mice, but not Dmp1 Cre-ERT2 VEGFAfl/fl (Dmp1 cKO) mice, showed impaired periosteal bone formation and angiogenesis in models of full fracture and stress fracture. Neither Osx cKO nor Dmp1 cKO mice demonstrated significant impairments in intramedullary bone formation and angiogenesis following cortical defect. These data suggest that VEGFA from early osteolineage cells (Osx+), but not mature osteoblasts/osteocytes (Dmp1+), is critical at the time of bone injury for rapid periosteal angiogenesis and woven bone formation during fracture repair. Whereas VEGFA from another cell source, not from the osteoblast cell lineage, is necessary at the time of injury for maximum cortical defect intramedullary angiogenesis and osteogenesis.
© 2019 American Society for Bone and Mineral Research. © 2019 American Society for Bone and Mineral Research.

Entities:  

Keywords:  CYTOKINES; GENETIC ANIMAL MODELS; INJURY/FRACTURE HEALING; OSTEOBLASTS

Mesh:

Substances:

Year:  2019        PMID: 31081125      PMCID: PMC6744295          DOI: 10.1002/jbmr.3755

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  76 in total

1.  The vascularity of atrophic non-unions.

Authors:  Harry C Brownlow; Anita Reed; A Hamish R W Simpson
Journal:  Injury       Date:  2002-03       Impact factor: 2.586

2.  Expression of vascular endothelial growth factors and their receptors during osteoblast differentiation.

Authors:  M M Deckers; M Karperien; C van der Bent; T Yamashita; S E Papapoulos; C W Löwik
Journal:  Endocrinology       Date:  2000-05       Impact factor: 4.736

3.  Prevention of fracture healing in rats by an inhibitor of angiogenesis.

Authors:  M R Hausman; M B Schaffler; R J Majeska
Journal:  Bone       Date:  2001-12       Impact factor: 4.398

Review 4.  VEGF receptor signaling and endothelial function.

Authors:  S Kliche; J Waltenberger
Journal:  IUBMB Life       Date:  2001-07       Impact factor: 3.885

5.  The angiogenic response to skeletal injury is preserved in the elderly.

Authors:  J T Street; J H Wang; Q D Wu; A Wakai; A McGuinness; H P Redmond
Journal:  J Orthop Res       Date:  2001-11       Impact factor: 3.494

6.  Role of fracture hematoma and periosteum during fracture healing in rats: interaction of fracture hematoma and the periosteum in the initial step of the healing process.

Authors:  A Ozaki; M Tsunoda; S Kinoshita; R Saura
Journal:  J Orthop Sci       Date:  2000       Impact factor: 1.601

7.  Is human fracture hematoma inherently angiogenic?

Authors:  J Street; D Winter; J H Wang; A Wakai; A McGuinness; H P Redmond
Journal:  Clin Orthop Relat Res       Date:  2000-09       Impact factor: 4.176

8.  VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation.

Authors:  H P Gerber; T H Vu; A M Ryan; J Kowalski; Z Werb; N Ferrara
Journal:  Nat Med       Date:  1999-06       Impact factor: 53.440

9.  Bone morphogenetic proteins stimulate angiogenesis through osteoblast-derived vascular endothelial growth factor A.

Authors:  Martine M L Deckers; Rutger L van Bezooijen; Geertje van der Horst; Jakomijn Hoogendam; Chris van Der Bent; Socrates E Papapoulos; Clemens W G M Löwik
Journal:  Endocrinology       Date:  2002-04       Impact factor: 4.736

10.  VEGF is required for growth and survival in neonatal mice.

Authors:  H P Gerber; K J Hillan; A M Ryan; J Kowalski; G A Keller; L Rangell; B D Wright; F Radtke; M Aguet; N Ferrara
Journal:  Development       Date:  1999-03       Impact factor: 6.868

View more
  15 in total

1.  Low bone mass and impaired fracture healing in mouse models of Trisomy21 (Down syndrome).

Authors:  Kirby M Sherman; Diarra K Williams; Casey A Welsh; Alexis M Cooper; Alyssa Falck; Shannon Huggins; Rihana S Bokhari; Dana Gaddy; Kent D McKelvey; Lindsay A Dawson; Larry J Suva
Journal:  Bone       Date:  2022-06-15       Impact factor: 4.626

2.  Deciphering Obesity-Related Gene Clusters Unearths SOCS3 Immune Infiltrates and 5mC/m6A Modifiers in Ossification of Ligamentum Flavum Pathogenesis.

Authors:  Baoliang Zhang; Lei Yuan; Guanghui Chen; Xi Chen; Xiaoxi Yang; Tianqi Fan; Chuiguo Sun; Dongwei Fan; Zhongqiang Chen
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-30       Impact factor: 6.055

3.  Interleukin-6 (IL-6) deficiency enhances intramembranous osteogenesis following stress fracture in mice.

Authors:  Brandon A Coates; Jennifer A McKenzie; Susumu Yoneda; Matthew J Silva
Journal:  Bone       Date:  2020-11-10       Impact factor: 4.398

Review 4.  The biology and treatment of acute long-bones diaphyseal fractures: Overview of the current options for bone healing enhancement.

Authors:  Giuseppe Marongiu; Andrea Dolci; Marco Verona; Antonio Capone
Journal:  Bone Rep       Date:  2020-01-28

Review 5.  Understanding Reactive Oxygen Species in Bone Regeneration: A Glance at Potential Therapeutics and Bioengineering Applications.

Authors:  Aaron J Sheppard; Ann Marie Barfield; Shane Barton; Yufeng Dong
Journal:  Front Bioeng Biotechnol       Date:  2022-02-07

6.  Fracture healing is delayed in the absence of gasdermin-interleukin-1 signaling.

Authors:  Kai Sun; Chun Wang; Jianqiu Xiao; Michael D Brodt; Luorongxin Yuan; Tong Yang; Yael Alippe; Huimin Hu; Dingjun Hao; Yousef Abu-Amer; Matthew J Silva; Jie Shen; Gabriel Mbalaviele
Journal:  Elife       Date:  2022-03-04       Impact factor: 8.713

Review 7.  Targeting regulation of stem cell exosomes: Exploring novel strategies for aseptic loosening of joint prosthesis.

Authors:  Tian-Liang Ma; Jing-Xian Chen; Zhuo-Ran Ke; Peng Zhu; Yi-He Hu; Jie Xie
Journal:  Front Bioeng Biotechnol       Date:  2022-08-10

8.  Silencing VEGFR-2 Hampers Odontoblastic Differentiation of Dental Pulp Stem Cells.

Authors:  Kajohnkiart Janebodin; Rakchanok Chavanachat; Aislinn Hays; Morayma Reyes Gil
Journal:  Front Cell Dev Biol       Date:  2021-06-25

9.  Deterioration of hematopoietic autophagy is linked to osteoporosis.

Authors:  Ye Yuan; Yixuan Fang; Lingjiang Zhu; Yue Gu; Lei Li; Jiawei Qian; Ruijin Zhao; Peng Zhang; Jian Li; Hui Zhang; Na Yuan; Suping Zhang; Quanhong Ma; Jianrong Wang; Youjia Xu
Journal:  Aging Cell       Date:  2020-03-25       Impact factor: 9.304

10.  Spatial Distribution of Macrophages During Callus Formation and Maturation Reveals Close Crosstalk Between Macrophages and Newly Forming Vessels.

Authors:  Jonathan Stefanowski; Annemarie Lang; Ariana Rauch; Linus Aulich; Markus Köhler; Alexander F Fiedler; Frank Buttgereit; Katharina Schmidt-Bleek; Georg N Duda; Timo Gaber; Raluca A Niesner; Anja E Hauser
Journal:  Front Immunol       Date:  2019-11-26       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.